Donthamsetti P.*, Gallo E.F.*, Buck D.C., Stahl E.L., Zhu Y., Lane R.L., Bohn L.M., Neve K.A., Kellendonk C., Javitch J.A. Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation Mol. Psychiatry (in press) 2018. *Both authors contributed equally to this work.
Gallo EF, Meszaros J, Sherman JD, Chohan MO, Teboul E, Choi CS, Moore H, Javitch JA, Kellendonk C. Dopamine D2 receptors on ventral striatal projection neurons increase motivation by decreasing inhibitory transmission to the ventral pallidum. Nature Communications. 2018; 9(1): 1086.
Gallo EF, Salling M, Feng B, Moron JA, Harrison NL, Javitch J, Kellendonk C. Upregulation of Dopamine D2 Receptors in the Nucleus Accumbens Indirect Pathway Increases Locomotion but does not Reduce Alcohol Consumption. Neuropsychopharmacology. 2015; 40(7):1609-18.
Anrather J, Gallo EF, Kawano T, Orio M, Abe T, Gooden C, Zhou P, Iadecola C. Purinergic signaling induces cyclooxygenase-1-dependent prostanoid synthesis in microglia: Roles in the outcome of excitotoxic brain injury. Public Library of Science ONE. 2011. 6(10): e25916.
Gallo EF, Iadecola C. Neuronal nitric oxide contributes to neuroplasticity-associated gene expression through cGMP, protein kinase G, and extracellular signal-regulated kinase. Journal of Neuroscience. 2011; 31(19):6947-6955
Zhou P, Qian L, Gallo EF, Deeb RS, Anrather J, Gross SS, Iadecola C. The scavenger receptor CD36 contributes to the neurotoxicity of bone marrow-derived monocytes through peroxynitrite production. Neurobiology of Disease. 2011; 42(3):292-299.
Tampellini D, Rahman N, Gallo EF, Huang Z, Dumont M, Capetillo-Zarate E, Ma T, Zheng R, Lu B, Nanus DM, Lin MT, Gouras GK. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. Journal of Neuroscience. 2009; 29(31):9704-9713.
Girouard H, Wang G, Gallo EF, Anrather J, Zhou P, Pickel VM, Iadecola C. NMDA receptor activation increases free radical production through nitric oxide and NOX2. Journal of Neuroscience. 2009; 29(8):2545-2552.
Park L, Gallo EF, Anrather J, Wang G, Norris EH, Paul J, Strickland S and Iadecola C: Key role of tissue plasminogen activator in neurovascular coupling. Proceedings of the National Academy of Sciences, USA. 2008; 105:1073-1078.
Kunz A, Park L, Abe T, Gallo EF, Anrather J, Zhou P and Iadecola C: Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. Journal of Neuroscience. 2007; 27:7083-7093.
Shen G, Saunée NA, Williams SR, Gallo EF, Schluchter WM and Bryant DA: Identification and characterization of a new class of bilin lyase: the cpcT gene encodes a bilin lyase responsible for attachment of phycocyanobilin to Cys-153 on the beta subunit of phycocyanin in Synechococcus sp. PCC 7002. Journal of Biological Chemistry. 2006; 281:17768-17778.
Reviews and Editorials
Gallo EF and Posner J. Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms. The Lancet Psychiatry. 2016; 3(6):555-67.
Iadecola C, Kahles T, Gallo EF, Anrather J. Neurovascular protection by ischemic tolerance: Role of nitric oxide. Journal of Physiology. 2011;589 (17):4137-45.
Gallo EF, Iadecola C. Balancing life and death in the ischemic brain: SIK and TORC weigh in. Neuron. 2011; 69(1):3-6.